title: The COMT Val108/158Met polymorphism and medial temporal lobe volumetry in patients with schizophrenia and healthy adults.
abstract: Abnormalities of the medial temporal lobe have been consistently demonstrated in schizophrenia. A common functional polymorphism, Val108/158Met, in the putative schizophrenia susceptibility gene, catechol-O-methyltransferase (COMT), has been shown to influence medial temporal lobe function. However, the effects of this polymorphism on volumes of medial temporal lobe structures, particularly in patients with schizophrenia, are less clear. Here we measured the effects of COMT Val108/158Met genotype on the volume of two regions within the medial temporal lobe, the amygdala and hippocampus, in patients with schizophrenia and healthy control subjects. We obtained MRI and genotype data for 98 schizophrenic patients and 114 matched controls. An automated atlas-based segmentation algorithm was used to generate volumetric measures of the amygdala and hippocampus. Regression analyses included COMT met allele load as an additive effect, and also controlled for age, intracranial volume, gender and acquisition site. Across patients and controls, each copy of the COMT met allele was associated on average with a 2.6% increase in right amygdala volume, a 3.8% increase in left amygdala volume and a 2.2% increase in right hippocampus volume. There were no effects of COMT genotype on volumes of the whole brain and prefrontal regions. Thus, the COMT Val108/158Met polymorphism was shown to influence medial temporal lobe volumes in a linear-additive manner, mirroring its effect on dopamine catabolism. Taken together with previous work, our data support a model in which lower COMT activity, and a resulting elevation in extracellular dopamine levels, stimulates growth of medial temporal lobe structures.
authors.affiliation: MGH/MIT/HMS Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, MA 02129-2000, USA. stefan@nmr.mgh.harvard.edu
authors.forename: Stefan
authors.initials: S
authors.lastname: Ehrlich
authors.forename: Eric M
authors.initials: EM
authors.lastname: Morrow
authors.forename: Joshua L
authors.initials: JL
authors.lastname: Roffman
authors.forename: Stuart R
authors.initials: SR
authors.lastname: Wallace
authors.forename: Melissa
authors.initials: M
authors.lastname: Naylor
authors.forename: H Jeremy
authors.initials: HJ
authors.lastname: Bockholt
authors.forename: Antonia
authors.initials: A
authors.lastname: Lundquist
authors.forename: Anastasia
authors.initials: A
authors.lastname: Yendiki
authors.forename: Beng-Choon
authors.initials: BC
authors.lastname: Ho
authors.forename: Tonya
authors.initials: T
authors.lastname: White
authors.forename: Dara S
authors.initials: DS
authors.lastname: Manoach
authors.forename: Vincent P
authors.initials: VP
authors.lastname: Clark
authors.forename: Vince D
authors.initials: VD
authors.lastname: Calhoun
authors.forename: Randy L
authors.initials: RL
authors.lastname: Gollub
authors.forename: Daphne J
authors.initials: DJ
authors.lastname: Holt
mesh_terms: D000465:Algorithms; D001931:Brain Mapping; D002394:Catechol O-Methyltransferase / Q000235:genetics*; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006801:Humans; D007090:Image Interpretation, Computer-Assisted; D008279:Magnetic Resonance Imaging; D020641:Polymorphism, Single Nucleotide; D012559:Schizophrenia / Q000235:genetics* / Q000473:pathology*; D013702:Temporal Lobe / Q000473:pathology*
chemical_list: D002394:Catechol O-Methyltransferase